Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000217428 | SCV000270453 | likely benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | p.Ala1704Ala in exon 34 of MYH6: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 24/66606 of Europ ean chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinst itute.org; dbSNP rs150450178). |
Labcorp Genetics |
RCV001081780 | SCV000557868 | likely benign | Hypertrophic cardiomyopathy 14 | 2024-12-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000463413 | SCV000729169 | likely benign | not provided | 2021-03-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000618953 | SCV000735598 | likely benign | Cardiovascular phenotype | 2016-11-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000217428 | SCV001519619 | benign | not specified | 2021-03-13 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000463413 | SCV005211356 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000463413 | SCV001743984 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000217428 | SCV001918206 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000463413 | SCV001932555 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000463413 | SCV001954429 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000463413 | SCV001967532 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004541322 | SCV004758036 | likely benign | MYH6-related disorder | 2020-08-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |